Title: Modified cap group suberoylanilide hydroxamic acid histone deacetylase inhibitor derivatives reveal improved selective antileukemic activity.
Journal: Journal of medicinal chemistry 20100422
149647-78-9
1132749-48-4
1345973-49-0 | AB-001 | AA009BMT | MFCD22419017
14341-88-9 | D-GLUTAMIC-2,3,3,4,4-D5 ACID | AA009BS1 | MFCD08704921
1431699-67-0 | (S)-Tedizolid | AA009C2S | MFCD25372025
1415246-68-2 | MMAF Hydrochloride | AA009CAQ | MFCD30207868
1375105-96-6 | Fas-in-1 | AA009CF4 | MFCD28411424
1313881-70-7 | ARQ 092 Free Base | AA009CJ6 | MFCD30187510
1251728-92-3 | 5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)FURO[2,3-B]PYRIDINE | AA009CTH | MFCD18259343
1364936-24-2 | Potassium (1-Boc-4-piperidinyloxy)methyltrifluoroborate | AA009DA9 | MFCD11505932
1212094-22-8 | Trans-4-(1-piperidinyl)tetrahydro-3-furanamine | AA009DNR | MFCD11617301
1215295-91-2 | 4-bromo-3-methoxybenzenesulfonyl chloride | AA009DQM | MFCD14702923